A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.: 6-thioguanine-related hepatotoxicity in inflammatory bowel disease

Autor: Thomas Klugmann, Nikolaus Pedarnig, Wolfgang Kreisel, Bruno Bonaz, Hans H Herfarth, Daan W. Hommes, Wolfgang Petritsch, Alexander Teml, Klaus Herrlinger, Walter Reinisch, Milan Lukas, Peter Knoflach, T Feichtenschlager, Bernd Bokemeyer, Sven Almer, Matthias Schwab, Julia Seiderer, Timothy H. Florin

Publikováno v: Wiener Klinische Wochenschrift
Wiener Klinische Wochenschrift, Springer Verlag, 2007, 119 (17-18), pp.519-26. ⟨10.1007/s00508-007-0841-0⟩

International audience; OBJECTIVE: Drug-induced liver injury was recently reported as a major complication leading to hepatic nodular regenerative hyperplasia (NRH) in patients with inflammatory bowel disease (IBD) and 6-thioguanine (6-TG) therapy. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8d39f706086382b41586bfce7e95f9
https://www.hal.inserm.fr/inserm-00388043/file/6TG_Hepatotoxicity.pdf